Home  /  About Us  /  News

For all media inquiries, or for more information about the IADR, please contact:

Elise Bender

Marketing & Communications Manager

Stay up to date on the latest news at IADR by reading our press releases. Use the search and keyword features on the left to sort past press releases. 

Better Reporting of Studies on Artificial Intelligence: CONSORT-AI and Beyond

0 891

Alexandria, Va., USA — An increasing number of studies on artificial intelligence (AI) are published in the dental and oral sciences but aspects of these studies suffer from a range of limitations. Standards towards reporting, like the recently published CONSORT-AI extension, can help to improve studies in this emerging field. Watch authors Falk Schwendicke and Joachim Krois of the Charité – Universitätsmedizin Berlin, Germany, discuss the Journal of Dental Research (JDR) article “Better Reporting of Artificial Intelligence (AI): CONSORT-AI and Beyond,” moderated by JDR Editor-in-Chief Nicholas Jakubovics, Newcastle University, England.

JDR Article “Factors Affecting Wound Healing” Wins SAGE Publishing 10-Year Impact Award

0 834

Alexandria, Va., USA — The International and American Associations for Dental Research (IADR/AADR) are pleased to announce that the Journal of Dental Research article “Factors Affecting Wound Healing,” by Shujuan Guo, West China Hospital of Stomatology, Chengdu, Sichuan, SAR, China, and Luisa A. DiPietro, University of Illinois at Chicago, USA, received a 10-Year Impact Award. This article had the second most citations in all SAGE journals from 2010-20.

COVID-19: Seroprevalence and Vaccine Responses in UK Dental Care Professionals

0 874

Alexandria, Va., USA — Dental care professionals are thought to be at enhanced risk of occupational exposure to SARS-CoV-2, but robust data to support this is lacking. The study "COVID-19: Seroprevalence and Vaccine Responses in UK Dental Care Professionals," published in the Journal of Dental Research (JDR), provides a longitudinal analysis of antibodies to SARS-CoV-2 spike glycoprotein, including early analysis of the impact of vaccination on the immune response.